Canadian partnership against cancer
French Version
In Brief
November 29, 2013
Ontario's successes in pathology reporting have potential to improve practice across Canada
As is your pathology, so is your medicine.

So said Dr. William Osler, a Canadian physician and one of the founding fathers of modern medicine. He was referring to the critical role that pathology - the study of tissue samples to diagnose disease - plays in diagnosing cancer and identifying treatment options.

Almost 100 years later, we've made tremendous progress in diagnosing and treating cancer, and there continue to be opportunities to improve. A recent article in the Journal of Oncology Practice has showcased the advancement of pathology reporting in Ontario. Initiated in 2008, Cancer Care Ontario's Pathology Reporting Project uses structured electronic checklists to make the reporting of diagnostic findings by pathologists more complete. This has resulted in the vast majority of Ontario hospitals implementing electronic tools to report cancer diagnosis, standardized reporting and more complete pathology reports. This leads to more effective care planning and better outcomes for patients. Read more...
Prevention Policies Directory supports change at the local level to improve the lives of Canadians
Bylaws for eight risk factors in 31 municipalities added

More than one in three Canadians will be diagnosed with cancer in their lifetime. Yet the World Cancer Research Fund estimates that a full third of cancer cases can be prevented by eliminating tobacco use, and another third avoided by a combination of eating nutritious food, limiting alcohol consumption, participating in regular physical activity and maintaining a healthy body weight.

While Canadians can take steps on their own to try to prevent these cancers, healthy public policies such as banning smoking on all city property or keeping junk food out of public buildings are just a few ways local governments can influence the health of residents directly, and help to reduce their risk of getting cancer. Read more...
New tutorial available: How cancer drug funding decisions are made

A new tutorial on cancer drug funding is now available through or

How cancer drug funding decisions are made is the result of a joint collaboration between the pan-Canadian Oncology Drug Review (pCODR) and the Canadian Partnership Against Cancer. The tutorial is designed for interested patients and caregivers and was developed with input from patient representatives, patient advocates, clinicians and decision-makers.

This tutorial explains the process that decision-makers in Canada follow to decide whether to publicly fund new cancer drugs. Topics covered include: which groups are involved in this process; how new drugs are evaluated; how health benefits, costs and values play into the decision; and accountability at different levels of the process.
New synoptic reporting information available on

New information about synoptic reporting in Canada is available on The
Synoptic Reporting microsite captures all
national activities around cancer pathology
reporting with:
Pathology and staging standards
Education sessions
Connections to resources and partner sites

Discover everything you need to know about standardized data reporting by watching synoptic reporting cancer registry and informatics education sessions and learn about the different vendor solutions available for synoptic reporting with vendor-led demonstrations. For more information, visit the Synoptic Reporting microsite.
Cancer research Community Forum webcast recording now available

A new landmark report, The second cancer research Community Forum was a great success! This special event, held in Toronto on November 3, 2013, provided an opportunity for the public to engage with Canada's leading cancer experts who presented the latest cancer research.

If you missed the event, you can now watch the complete webcast recording, by clicking on this link:
Reminder: The Canadian Partnership Against Cancer needs your feedback!

To continuously improve our monthly e-bulletin, we are conducting a survey to gather feedback from our subscribers. Please help us ensure you receive interesting and relevant cancer control information by completing a quick survey here by Friday, November 29, 2013.

Thank you in advance for your feedback!
The Partnership welcomes new Board members

The Partnership is pleased to welcome seven new members to its Board of Directors who have joined since March 2013: Ewan Clark, Karen Herd, Dr. Eshwar Kumar, Mary Catherine Lindberg, Helen Mallovy Hicks, Crystal Nett and Arlene Paton.

The Partnership's Board of Directors reflects the broad range of stakeholders in the cancer control domain. The Board is made up of representatives from cancer organizations, the provinces/territories; patient, family and survivor groups; the Aboriginal community and the federal government.
CancerView Canada

New in cancer control

Visit Cancerview for the latest news from the cancer control community in Canada.

Now featured:
Canada Health Infoway's e-connect Impact Challenge
UHN's Personalizing Cancer Medicine in 2014 event
New quality assurance guidelines for Canadian radiation treatment programs from the Canadian Partnership for Quality Radiotherapy

Forward this email

The next In Brief will be
published in December.

Canadian Partnership Against Cancer 1 University Ave. Suite 300 Toronto, Ontario M5J 2P1 Canada

To remove your name from our mailing list please click here. Privacy policy. Forward to a friend.  Subscribe

Production of this publication has been made possible through a financial contribution from Health Canada, through the Canadian Partnership Against Cancer. The views expressed herein represent the views of the Canadian Partnership Against Cancer.